H L Liston

Summary

Affiliation: Medical University of South Carolina
Country: USA

Publications

  1. ncbi Drug glucuronidation in clinical psychopharmacology
    H L Liston
    Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, USA
    J Clin Psychopharmacol 21:500-15. 2001
  2. ncbi Charleston Antidepressant Drug Interactions Surveillance Program (CADISP)
    C L DeVane
    Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, 67 President Street, Charleston, SC 29425 0742, USA
    Psychopharmacol Bull 35:50-61. 2001
  3. ncbi Intranasal sumatriptan in post-ECT headache: results of an open-label trial
    J S Markowitz
    The Institute of Psychiatry, Department of Pharmaceutical Sciences, Medical University of South Carolina, Charleston, South Carolina 29425 0742, USA
    J ECT 17:280-3. 2001
  4. ncbi An explanation of the second-dose effect in pharmacokinetics and its meaning for clinical psychopharmacology
    C L DeVane
    Drug Dispositions and Pharmacogenetics Laboratory, Medical University of South Carolina, Charleston, USA
    Psychopharmacol Bull 35:42-52. 2001

Collaborators

Detail Information

Publications4

  1. ncbi Drug glucuronidation in clinical psychopharmacology
    H L Liston
    Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, USA
    J Clin Psychopharmacol 21:500-15. 2001
    ..This review summarizes the relevant literature pertaining to drug glucuronidation and its implications for clinical psychopharmacology...
  2. ncbi Charleston Antidepressant Drug Interactions Surveillance Program (CADISP)
    C L DeVane
    Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, 67 President Street, Charleston, SC 29425 0742, USA
    Psychopharmacol Bull 35:50-61. 2001
    ..These data do not eliminate the need for caution when prescribing antidepressants with the potential for causing metabolic interactions, but do help allay the fear that such interactions are highly prevalent and routinely hazardous...
  3. ncbi Intranasal sumatriptan in post-ECT headache: results of an open-label trial
    J S Markowitz
    The Institute of Psychiatry, Department of Pharmaceutical Sciences, Medical University of South Carolina, Charleston, South Carolina 29425 0742, USA
    J ECT 17:280-3. 2001
    ..The aim of the present open-label study was to assess the efficacy and tolerability of intranasal sumatriptan for post-ECT headache...
  4. ncbi An explanation of the second-dose effect in pharmacokinetics and its meaning for clinical psychopharmacology
    C L DeVane
    Drug Dispositions and Pharmacogenetics Laboratory, Medical University of South Carolina, Charleston, USA
    Psychopharmacol Bull 35:42-52. 2001
    ..An appreciation of the assumptions and limitations of the second-dose effect provides a better understanding of the observed effects of many psychoactive drugs after repeated administration...